Celecoxib/famciclovir - Dogwood Therapeutics
Alternative Names: Famciclovir/celecoxib; IMC-1Latest Information Update: 13 Nov 2024
At a glance
- Originator Innovative Med Concepts
- Developer Dogwood Therapeutics
- Class Antimigraines; Antineoplastics; Antipyretics; Antirheumatics; Antivirals; Irritable bowel syndrome therapies; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Nucleosides; Purines; Pyrazoles; Small molecules; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; DNA-directed DNA polymerase inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Fibromyalgia
- No development reported Chronic fatigue syndrome; Irritable bowel syndrome